4D Molecular Therapeutics, Inc. (FDMT)
8.61
-0.37
(-4.12%)
USD |
NASDAQ |
Mar 20, 16:00
8.63
+0.02
(+0.23%)
After-Hours: 20:00
4D Molecular Therapeutics EPS Diluted (Quarterly) : 0.3367 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.40M |
| Revenue (Quarterly) | 85.09M |
| Total Expenses (Quarterly) | 65.69M |
| Enterprise Value | 57.94M |
| Gross Profit Margin (Quarterly) | 97.67% |
| Profit Margin (Quarterly) | 22.80% |
| Earnings Yield | -29.21% |
| Normalized Earnings Yield | -29.21 |